Stay updated on Safety of SNA-120 in Psoriasis Clinical Trial

Sign up to get notified when there's something new on the Safety of SNA-120 in Psoriasis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of SNA-120 in Psoriasis Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed the notice about government funding and the earlier Revision: v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-11T05:13:31.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Notice added: a government-funding lapse advisory appears on the page and the revision is updated to v3.4.1 (previously v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T04:45:40.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Added a Show glossary option and updated QC-related text and revision numbers (Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0) with capitalization adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T02:54:51.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    Revision notes show an addition of Revision: v3.3.4 and a deletion of Revision: v3.3.3.
    Difference
    0.0%
    Check dated 2026-01-14T01:54:18.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    A consolidated Locations section has been added, listing all participating sites by state/province and country (e.g., Alabama, California, Florida, British Columbia, Ontario, Quebec). The previous location subsections were removed, and the study record updated to Revision: v3.3.3.
    Difference
    1%
    Check dated 2025-12-23T09:21:22.000Z thumbnail image
  6. Check
    83 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2; no study content or user-facing information was changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T17:04:42.000Z thumbnail image

Stay in the know with updates to Safety of SNA-120 in Psoriasis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of SNA-120 in Psoriasis Clinical Trial page.